CATHERINE LESSON: Open Payments
NPI 1568846806 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 11 payments from 7 companies in 2025. Trend: 2023 $249 · 2024 $331 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: REXULTI, TRINTELLIX, INGREZZA, VRAYLAR, AUSTEDO XR, FANAPT, SPRAVATO.
Industry payments across NY — which companies pay providers there.
